首页> 美国卫生研究院文献>PLoS Clinical Trials >Vaccine Platforms Combining Circumsporozoite Protein and Potent Immune Modulators, rEA or EAT-2, Paradoxically Result in Opposing Immune Responses
【2h】

Vaccine Platforms Combining Circumsporozoite Protein and Potent Immune Modulators, rEA or EAT-2, Paradoxically Result in Opposing Immune Responses

机译:结合环子孢子蛋白和强效免疫调节剂,rEA或EAT-2的疫苗平台,自相矛盾地导致了相反的免疫反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundMalaria greatly impacts the health and wellbeing of over half of the world's population. Promising malaria vaccine candidates have attempted to induce adaptive immune responses to Circumsporozoite (CS) protein. Despite the inclusion of potent adjuvants, these vaccines have limited protective efficacy. Conventional recombinant adenovirus (rAd) based vaccines expressing CS protein can induce CS protein specific immune responses, but these are essentially equivalent to those generated after use of the CS protein subunit based vaccines. In this study we combined the use of rAds expressing CS protein along with rAds expressing novel innate immune response modulating proteins in an attempt to significantly improve the induction of CS protein specific cell mediated immune (CMI) responses.
机译:背景疟疾极大地影响了世界一半以上人口的健康。有希望的疟疾疫苗候选者已尝试诱导对环子孢子(CS)蛋白的适应性免疫反应。尽管包含有效的佐剂,但这些疫苗的保护功效有限。表达CS蛋白的基于常规重组腺病毒(rAd)的疫苗可诱导CS蛋白特异性免疫反应,但这些基本上等同于使用基于CS蛋白亚基的疫苗后产生的疫苗。在这项研究中,我们结合使用表达CS蛋白的rAds和表达新型先天免疫应答调节蛋白的rAds的使用,以尝试显着改善CS蛋白特异性细胞介导的免疫(CMI)反应的诱导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号